Shares of the U.S.’s largest refrigerant reclaimer drop as Q3 sales fall short of consensus, but favorable upcoming regulatory changes keep it poised for continued profit and cash flow outperformance ahead.
Hudson Technologies (HDSN) reported seemingly mixed Q3 results last night. Specifically, due to lower selling prices for certain refrigerants, revenues for the [.]
Despite recent customer losses forcing the healthcare giant to slightly reduce its preliminary earnings outlook for 2024, it continues to be well positioned for significant additional cash flow generation ahead.
Based strictly on the performance of the big three major averages the S&P 500, Dow Jones and NASDAQ which are all up at least 1.4% through the first 16 days of [.]
We are in what is historically considered the slow season of the investing world, but there are still opportunities for value-minded investors willing to turn over a rock or two. Here are three undervalued stocks to consider.